[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353498-105":59,"doc-detail-353498-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","microbiome-modulation-of-tumorigenesis-and-immune-responses","Microbiome modulation of tumorigenesis and immune responses","","The microbiome functions as a critical, context-dependent regulator of tumorigenesis and anticancer immunity, with effects ranging from promoting cancer progression to providing protection. Dual outcomes arise through interconnected mechanisms such as chronic inflammation, modulation of immune responses, and changes in host metabolic signaling. Organ-specific microbiome–cancer interactions shape malignancies in colon, breast, lung, and more. Clinically, the microbiome influences responses to cancer therapies, especially immunotherapies like immune checkpoint blockade and CAR-T cells. Emerging microbiome-modulating strategies are promising yet limited by individual variability and dynamic immune–microbial interplay, while offering potential for precision oncology via personalized prevention and treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/microbiome-modulation-of-tumorigenesis-and-immune-responses/353498/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/microbiome-modulation-of-tumorigenesis-and-immune-responses/353498.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the microbiome influence tumorigenesis and anticancer immunity?","Question",{"text":112,"@type":113},"It can either promote cancer progression or protect against malignancy, depending on context. Mechanisms include chronic inflammation, immune modulation, and altered host metabolic signaling.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which cancer therapies are affected by microbiome composition?",{"text":117,"@type":113},"The microbiome significantly affects patient responses to cancer therapies, particularly immunotherapies such as immune checkpoint blockade (ICB) and CAR-T cell therapy.",{"name":119,"@type":110,"acceptedAnswer":120},"What challenges limit microbiome-targeted therapeutic strategies?",{"text":121,"@type":113},"Key challenges include variability between individuals’ microbiomes and the dynamic interplay between the immune system and microbial communities.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353498,1790142741,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Chen et al.  \nJournal of Biomedical Science (2026) 33:4 [https://doi.org/10.1186/s12929-025-01208-9](https://doi.org/10.1186/s12929-025-01208-9)  \nREVIEW Open Access  \nMicrobiome modulation of tumorigenesis and immune responses  \nYuning Chen1,2, Ying Fang1,2, Zibai Lyu1,2, Yanxin Tian1,2, Siyue Niu1,2, Yan‑Ruide Li 1,2* and Lili Yang1,2,3,4,5,6*  \nAbstract  \nThe microbiome has emerged as a critical, context‑dependent regulator of tumorigenesis and anticancer immunity, capable of either promoting cancer progression or protecting against malignancy. This dual role is mediated by mul‑ tiple interconnected mechanisms—including chronic inflammation, modulation of immune responses, and altera‑ tions in host metabolic signaling. These microbiome‑cancer interactions vary across organs, influencing malignancies in the colon, breast, lung, and beyond. Clinically, the microbiome significantly affects patient responses to cancer therapies, particularly immunotherapies such as immune checkpoint blockade (ICB) and chimeric antigen receptor (CAR)‑T cell therapy. Although emerging therapeutic strategies aimed at modulating the microbiome have shown promising early results, challenges remain, including individual microbiome variability and the dynamic interplay between the immune system and microbial communities. Nevertheless, harnessing the microbiome holds significant potential to transform precision oncology, offering personalized cancer prevention and treatment strategies tailored to each patient’s unique microbial ecosystem.  \nKeywords Microbiome, Microbial metabolites, Tumorigenesis, Immune modulation, Cancer immunotherapy, Dysbiosis, Microbiome‑targeted therapies  \n*Correspondence: Yan‑Ruide Li [charlie.li@ucla.edu](charlie.li@ucla.edu)[ ](charlie.li@ucla.edu)Lili Yang [liliyang@ucla.edu](liliyang@ucla.edu)  \n1 Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA  \n2 Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095, USA  \n3 Molecular Biology Institute, University of California, Los Angeles, CA 90095, USA  \n4 Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA 90095, USA  \n5 Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA  \n6 Parker Institute for Cancer Immunotherapy, University of California, Los Angeles, Los Angeles, CA 90095, USA  \nIntroduction  \nOver the past decade, it has become increasingly clear that the commensal microbiome plays a pivotal and context-dependent role in cancer biology. The microorganisms inhabiting barrier sites can profoundly influence tumor initiation, progression, and the host immune response to cancer. Also, disruptions in the normal microbial community, dysbiosis, are now frequently associated with malignancy and have been proposed as a new hallmark of cancer [1, 2]. On the other hand, the microbiome can exert protective effects and maintain immune surveillance in some contexts, underscoring the dualistic, context-dependent nature of host-microbiome interactions in cancer. An increasing number of studies underscore that the net effect of the microbiome on cancer is highly situation-specific: while some microbial communities promote inflammation and immune evasion that favor tumor growth, others can stimulate anti-tumor immunity or produce metabolites that restrain neoplastic development [2, 3]. As a result, the microbiome has  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third p","cbCaicmtWityYBXg","https://ap.wps.com/l/cbCaicmtWityYBXg","pdf",7317993,33,"English","# Abstract\n# Introduction","[{\"question\":\"How does the microbiome influence tumorigenesis and anticancer immunity?\",\"answer\":\"It can either promote cancer progression or protect against malignancy, depending on context. Mechanisms include chronic inflammation, immune modulation, and altered host metabolic signaling.\"},{\"question\":\"Which cancer therapies are affected by microbiome composition?\",\"answer\":\"The microbiome significantly affects patient responses to cancer therapies, particularly immunotherapies such as immune checkpoint blockade (ICB) and CAR-T cell therapy.\"},{\"question\":\"What challenges limit microbiome-targeted therapeutic strategies?\",\"answer\":\"Key challenges include variability between individuals’ microbiomes and the dynamic interplay between the immune system and microbial communities.\"}]","Microbiome modulation of tumorigenesis and immune responses | PDF",1790105789,83,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4223791fb3385bc81a8f31cef512469a.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40e4be202120d62fb6d2c980d5d272d5.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4dc5e65f36d3a7661b7e56f69c7c2f09.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/668bd829b92b3903d5f5dd8e06163c1c.webp",980,1301]